Plaintiffs Win $72M in Hormone Replacement Therapy Case

The Pennsylvania Record reports a Philadelphia jury awarded three women a collective $72.6 million against Pfizer; the plaintiffs alleged that their breast cancer was caused by hormone therapy medications manufactured by Wyeth since acquired by Pfizer.

– SBS